-       Report 
   - October 2025
    -  196 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                -       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - November 2025
    -  186 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                  -       Clinical Trials 
   - April 2025
    -  80 Pages 
    Global
   
   From       €1436EUR$1,600USD£1,260GBP 
      €1795EUR$2,000USD£1,575GBP 
                  -       Report 
   - July 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
      €4352EUR$4,850USD£3,820GBP 
                   -       Report 
   - July 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
      €4352EUR$4,850USD£3,820GBP 
                -       Report 
   - September 2025
    -  150 Pages 
    Global
   
   From       €3993EUR$4,450USD£3,505GBP 
                -       Report 
   - July 2025
    -  271 Pages 
    Global
   
   From       €4482EUR$4,995USD£3,934GBP 
                -       Report 
   - July 2025
    -  80 Pages 
    United States
   
   From       €5339EUR$5,950USD£4,686GBP 
                -       Report 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2503EUR$2,789USD£2,196GBP 
                -       Report 
   - June 2025
    -  400 Pages 
    Global
   
   From       €4441EUR$4,949USD£3,898GBP 
                  -       Report 
   - August 2025
    -  186 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Report 
   - August 2025
    -  190 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Report 
   - August 2025
    -  188 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                -       Report 
   - July 2025
    -  175 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - January 2025
    -  175 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                  -       Report 
   - April 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
      €4352EUR$4,850USD£3,820GBP 
                -       Report 
   - April 2025
    -  163 Pages 
    United States
   
   From       €2243EUR$2,500USD£1,969GBP 
                -       Report 
   - May 2019
    -  89 Pages 
    Global
   
   From       €808EUR$900USD£709GBP 
                -       Report 
   - May 2024
    -  110 Pages 
    Global
   
   From       €5339EUR$5,950USD£4,686GBP 
             
         Attention Deficit Hyperactivity Disorder (ADHD) is a mental disorder that affects a person's ability to focus and control their behavior. Mental Disorders Drugs are used to treat the symptoms of ADHD, such as difficulty concentrating, impulsivity, and hyperactivity. Stimulant medications are the most commonly prescribed drugs for ADHD, and they work by increasing the levels of dopamine and norepinephrine in the brain. Non-stimulant medications, such as atomoxetine, are also used to treat ADHD.
The    ADHD Drug market is highly competitive, with a number of pharmaceutical companies offering various medications. Companies such as Eli Lilly, Shire, Novartis, and Pfizer are some of the major players in the market. Other companies such as Teva Pharmaceuticals, Sun Pharmaceuticals, and Mylan also offer ADHD medications. These companies are constantly innovating and developing new drugs to meet the needs of patients with ADHD. Show Less   Read more